Ferritin Quantitative Test

NGAL Rapid Quantitative Test

NGAL (neutrophil gelatinase-associated lipocalin, lipocalin-2, sidero- calin) is a novel biomarker for diagnosing acute kidney injury (AKI). Under normal conditions NGAL levels are low in urine and plasma Still, they rise sharply from basal levels in response to kidney injury to reach diagnostic levels within a very short time - as much as 24 hours or more before any significant rise in serum creatinine.

Product Detail

Product Specification

Specimen Types
Urine
Specimen Capacity
10μL
Reaction Time
10min
Sample Capacity
80μL
Detection Range
10-5000ng/mL



Clinical Significance

Acute kidney injury (AKI) is one of the major causes of morbidity and mortality encountered by hospitalized patients, especially intensive care centers. Early detection may improve the hospital stay, patients prognosis, and reduce expensive medical costs.
Cited from: Cai-Mei Zheng, Min-Tser Liao et al.,“ Biomarkers in Acute
Kidney Injury”, Open Journal of Nephrology, Vol.3 No.1(2013).



Aplication

  • Early diagnosis of AKI to allow earlier initiation of appropriate management
  • Risk stratification of AKI
  • Prediction of clinical outcomes (dialysis, in-hospital death, length of hospital stay, mortality)
  • Monitor response to therapy

Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
Biotime HbA1c Rapid Quantitative Test
HbA1c Rapid Quantitative Test
HbA1c is the product of the hemoglobin combining with blood glucose in red blood cells, which can reflect the average blood glucose level over the amid 2-3 months.
biotime MAU Rapid Quantitative Test
MAU Rapid Quantitative Test
MAU(Microalbumin) occurs when the kidney leaks small amounts of albumin into the urine, which is an early marker of kidney damage.
Cys C Rapid Quantitative Test
Cys-C Rapid Quantitative Test
Serum Cystatin C(Cys-C) has been proposed as a marker of glomerular filtration rate(GFR). Serum creatinine (creatinine) is widely used to estimate the glomerular filtration rate, but its tubular secretion, dependence on muscle mass, alteration in some inflammatory diseases, and analytical interferences can limit its utility. Thus, Cys-C has been proposed as a novel biomarker of kidney function.
Biotime HbA1c Rapid Quantitative Test
HbA1c Rapid Quantitative Test
HbA1c is the product of the hemoglobin combining with blood glucose in red blood cells, which can reflect the average blood glucose level over the amid 2-3 months.
hs-cTnI Rapid Quantitative Test (Chemiluminescence Immunoassay)
hs-cTnI Rapid Quantitative Test (Chemiluminescence Immunoassay)
hs-cTnI Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the high sensitivity cardiac troponin I (hs-cTnI) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.
Biotime Myo Rapid Quantitative Test
Myo Rapid Quantitative Test
Myo is the earliest marker after AMI, and it is a sensitive and accurate indicator to judge whether there is reperfusion in thrombolytic therapy. Biotime Myo test kit is mainly used to detect Myo quantity in human serum and plasma samples.
Malaria Pf/Pv Antigen Qualitative Rapid Test
Malaria Pf/Pv Antigen Rapid Test
The Malaria P.f/P.v Antigen Rapid Test is a lateral flow immunoassay for the qualitative detection of Histidine-Rich Protein II (HRP-II) specific to Plasmodium falciparum (P.f) and Plasmodium lactate dehydrogenase (pLDH) specific to Plasmodium vivax (P.v) in human whole blood specimen. It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with Malaria. For professional in vitro diagnostic use only.
hs cTnI Rapid Quantitative Test
hs cTnI Rapid Quantitative Test
cTnI, a crucial cardiac biomarker, assists in detecting and managing acute myocardial infarction and assessing patient risk in cardiovascular events. Biotime's hs-cTnI offers high sensitivity, compatibility with versatile samples, and stable performance. Trust our ideal biomarker for comprehensive acute coronary syndrome evaluation.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact